Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: First-time collection results and evaluation of subsequent cryopreservation

Transfusion

Volumn 53, Issue 4, 2013, Pages 747-756

  Steininger, Philipp A ^a   Smith, Richard ^a   Geier, Christoph ^a   Zimmermann, Robert ^a   Eckstein, Reinhold ^a   Strasser, Erwin F ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN;

ADULT; APHERESIS; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; BODY MASS; CELL COUNT; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMING UNIT; CRYOPRESERVATION; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FREEZE THAWING; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; PILOT STUDY; PROSPECTIVE STUDY;

ADULT; ANTIGENS, CD14; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD45; BIOLOGICAL MARKERS; BLOOD PRESERVATION; CELL SURVIVAL; CRYOPRESERVATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84876115444     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03787.x     Document Type: Article

References (40)

1. Tey SK, Bollard CM, Heslop HE,. Adoptive T-cell transfer in cancer immunotherapy. Immunol Cell Biol 2006; 84: 281-9.
2. Peggs KS, Mackinnon S,. Cellular therapy: donor lymphocyte infusion. Curr Opin Hematol 2001; 8: 349-54.
3. Rezvani AR, Storb RF,. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 2008; 30: 172-9.
4. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF,. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010; 363: 411-22.
5. Rice AM, Jones KL, Hart DN,. DC preparations for therapy. Cytotherapy 2004; 6: 99-104.
6. Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, Schuler G,. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods 2005; 298: 61-72.
7. Brauninger S, Bialleck H, Thorausch K, Felt T, Seifried E, Bonig H,. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems. Transfusion 2012; 52: 1137-45.
8. Schuurhuis GJ, Muijen MM, Oberink JW, de Boer F, Ossenkoppele GJ, Broxterman HJ,. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001; 27: 487-98.
9. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE,. Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001; 3: 377-86.
10. Scientific Advisory Board of the German Medical Association and the Paul Ehrlich Institute. [Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie)]. Cologne: Deutscher Ärzteverlag; 2001.
11. Brauninger S, Bialleck H, Thorausch K, Seifried E, Bonig H,. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial. Vox Sang 2011; 101: 237-46.
12. Rodrigues JP, Paraguassú-Braga FH, Carvalho L, Abdelhay E, Bouzas LF, Porto LC,. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 2008; 56: 144-51.
13. Barker JN, Abboud M, Rice RD, Hawke R, Schaible A, Heller G, La Russa V, Scaradavou A,. A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biol Blood Marrow Transplant 2009; 15: 1596-602.
14. Craiu A, Saito Y, Limon A, Eppich HM, Olson DP, Rodrigues N, Adams GB, Dombkowski D, Richardson P, Schlossman R, Choi PS, Grogins J, O'Connor PG, Cohen K, Attar EC, Freshman J, Rich R, Mangano JA, Gribben JG, Anderson KC, Scadden DT,. Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function. Blood 2005; 105: 2235-8.
15. Strasser EF, Zimmermann R, Weisbach V, Ringwald J, Zingsem J, Eckstein R,. Mononuclear cell variability and recruitment in non-cytokine-stimulated donors after serial 10-liter leukapheresis procedures. Transfusion 2005; 45: 445-52.
16. Strasser EF, Dittrich S, Weisbach V, Zimmermann R, Ringwald J, Achenbach S, Zingsem J, Eckstein R,. Comparison of two mononuclear cell program settings on two apheresis devices intended to collect high yields of CD14+ and CD3+ cells. Transfusion 2004; 44: 1104-11.
17. To LB, Levesque JP, Herbert KE,. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011; 118: 4530-40.
18. Moog R,. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci 2008; 38: 229-36.
19. Gertz MA,. Current status of stem cell mobilization. Br J Haematol 2010; 150: 647-62.
20. Strasser EF, Hendelmeier M, Weisbach V, Zimmermann R, Ringwald J, Juntke R, Sauer G, Zingsem J, Eckstein R,. CD 14+ cell collection in non-cytokine-stimulated donors with the COM.TEC cell separator. Transfusion 2006; 46: 66-73.
21. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della Cuna G,. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705-8.
22. Erdmann M, Dörrie J, Schaft N, Strasser E, Hendelmeier M, Kämpgen E, Schuler G, Schuler-Thurner B,. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother 2007; 30: 663-74.
23. Nquyen XD, Müller-Berghaus J, Kälsch T, Schadendorf D, Borggrefe M, Klüter H,. Differentiation of monocyte-derived dendritic cells under the influence of platelets. Cytotherapy 2008; 10: 720-9.
24. Celluzzi CM, Welbon C,. Dendritic cell culture: a simple closed culture system using ficoll, monocytes, and a table-top centrifuge. J Hematother Stem Cell Res 2003; 12: 575-85.
25. Kissel K, Berber S, Nockher A, Santoso S, Bein G, Hackstein H,. Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 2006; 46: 818-27.
26. Ikeda K, Ohto H, Kanno T, Ogata T, Noji H, Ogawa K, Maruyama Y,. Automated programs for collection of mononuclear cells and progenitor cells by two separators for peripheral blood progenitor cell transplantation: comparison by a randomized crossover study. Transfusion 2007; 47: 1234-40.
27. Berz D, McCormack EM, Winer ES, Colvin GA, Quesenberry PJ,. Cryopreservation of hematopoietic stem cells. Am J Hematol 2007; 82: 463-72.
28. Watt SM, Austin E, Armitage S,. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use. Methods Mol Biol 2007; 368: 237-59.
29. Baust JM, Vogel MJ, Van Buskirk R, Baust JG,. A molecular basis of cryopreservation failure and its modulation to improve cell survival. Cell Transplant 2001; 10: 561-71.
30. Clarke DM, Yadock DJ, Nicoud IB, Mathew AJ, Heimfeld S,. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy 2009; 11: 472-9.
31. Bakken AM,. Cryopreservation human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006; 1: 47-54.
32. Feugier P, Bensoussan D, Girard F, Alla F, Schuhmacher A, Latger-Cannard V, Hulin C, Witz F, Witz B, Carret AS, Bordigoni P, Lederlin P, Janot C,. Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells. Transfusion 2003; 43: 878-84.
33. Abrahamsen JF, Wentzel-Larsen T, Bruserud O,. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2×10(6) CD34+ cells/kg. Cytotherapy 2004; 6: 356-62.
34. Reich-Slotky R, Colovai AI, Semidei-Pomales M, Patel N, Cairo M, Jhang J, Schwartz J,. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Vox Sang 2008; 94: 351-7.
35. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK,. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 1003-10.
36. Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder MC,. Hematopoietic stem/progenitor cells, generation of induces pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011; 117: 4773-7.
37. Burger SR, Kadidlo D, McCullough J,. Improved progenitor assay standardization using peripheral blood progenitor cells from a donor treated with granulocyte-colony-stimulating factor. Transfusion 1999; 39: 451-6.
38. Majado MJ, Salgado-Cecilia G, Blanquer M, Funes C, González- García C, Insausti CL, Parrado A, Morales A, Minguela A, Moraleda JM,. Cryopreservation impact on blood progenitor cells: influence of diagnoses, mobilization treatments, and cell concentration. Transfusion 2011; 51: 799-807.
39. Solves P, Planelles D, Mirabet V, Blasco I, Carbonell-Uberos F, Soler MA, Roig RJ,. Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking. Clin Lab Haematol 2004; 26: 413-8.
40. Douay L, Lopez M, Gorin NC,. A technical bias: differences in cooling rates prevent ampoules from being a reliable index of stem cell cryopreservation in large volumes. Cryobiology 1986; 23: 296-301.